Abstract
Introduction Disturbed interpersonal attunement is a core but poorly operationalised feature of the psychopathology of schizophrenia. Language Style Matching (LSM), the largely unconscious alignment of two speakers’ function words during ordinary conversation, offers an observable, dialogue-derived index of this dyadic attunement. An open question is where altered alignment mark who a patient (a stable trait of inner experience) is or how they are (a fluctuating state that shifts with symptom severity)?
Objective To characterise LSM over 12 months in early psychosis relative to controls, and to test, at both between- and within-person levels, whether alignment covaries with core psychopathological dimensions across self-referential (autobiographical) and externally directed discourse.
Methods First-episode and recent-onset patients (n = 109) and controls (n = 60) completed semi- structured interviews at baseline and 12 months. LSM was computed per context and modelled with linear mixed-effects; a Mundlak decomposition partitioned the LSM–symptom association into between- and within-person components.
Results LSM is not a fixed trait: groups were indistinguishable at baseline but diverged by 12 months (Group × Timepoint β = −0.018, p = .029), and the deficit was specific to autobiographical speech.
Within individuals, autobiographical alignment tightened as formal thought disorder rose above a patient’s own average and as negative symptoms worsened, independent of antipsychotic dose.
Conclusion Patients aligned less than controls when speaking about themselves, yet aligned more as symptoms deteriorated — a shift from self-generated toward partner-scaffolded speech when self- organisation fails. LSM indexes disordered self-anchoring and interpersonal attunement in the negative–disorganized dimension of psychosis.
Competing Interest Statement
Conflict of Interest Statement LP reports personal fees for serving as chief editor from the Canadian Medical Association Journals, speaker or advisor honorarium from Janssen Canada, Bausch Health, Bristol-Myers Squibb, and Otsuka Canada, SPMM Course Limited, UK, book royalties from Oxford University Press, investigator-initiated educational grants from Otsuka Canada outside the submitted work, in the last 3 years. Funding Sources The research of L. Palaniyappan is supported by Monique H. Bourgeois Chair in Developmental Disorders and the Graham Boeckh Foundation. He receives a salary award from the Fonds de recherche du Quebec-Sante (FRQS: 366934) and supported by the FRQS through a Research Centre Grant to Douglas Research Centre (https://doi.org/10.69777/5230). Data collection/curation was supported by Academic Medical Organization of Southwestern Ontario (AMOSO) Innovation Fund Project #INN22-015 and Canadian Institutes of Health Research (CIHR) - Strategy for Patient Oriented Research Priority Announcement (SPOR, Grant number PJK192157) and Project Grant (Grant number PJT195903). A. Voppel is supported by NARSAD Young Investigator Grant 32574 from the Brain & Behaviour Research Foundation. The funder had no role in the design, data collection, data analysis, and reporting of this study. F. Meister and P. Dzialoszynski report no funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study protocol was reviewed and approved by the Research Ethics Board at Western University, Ontario, Canada [Project ID: 119548].
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Access to the dataset used in this article can be requested at: https://talkbank.org/psychosis/access/English/Palaniyappan/Discourse-UWO.html
https://talkbank.org/psychosis/access/English/Palaniyappan/Discourse-UWO.html
Funder Information Declared
